Kathleen Laporte - Feb 1, 2024 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Kathleen LaPorte
Stock symbol
ETNB
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/5/2024, 08:11 PM
Previous filing
Sep 14, 2023
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +45.2K $0.00 45.2K Feb 1, 2024 Common Stock 45.2K $9.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 45,150 shares of the Issuer's Common Stock, which will vest in full on February 1, 2025, subject to the Reporting Person's continued service to the Issuer through such date.